- Home
- PATH vs CRL Comparison
PATH vs CRL Comparison
Compare PATH & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PATH
- CRL
- Stock Information
- Founded
- PATH 2005
- CRL 1947
- Country
- PATH United States
- CRL United States
- Employees
- PATH N/A
- CRL N/A
- Industry
- PATH Computer Software: Prepackaged Software
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PATH Technology
- CRL Health Care
- Exchange
- PATH Nasdaq
- CRL Nasdaq
- Market Cap
- PATH 6.5B
- CRL 7.1B
- IPO Year
- PATH 2021
- CRL 2000
- Fundamental
- Price
- PATH $12.80
- CRL $151.05
- Analyst Decision
- PATH Hold
- CRL Hold
- Analyst Count
- PATH 18
- CRL 15
- Target Price
- PATH $13.97
- CRL $186.38
- AVG Volume (30 Days)
- PATH 10.2M
- CRL 832.4K
- Earning Date
- PATH 05-29-2025
- CRL 08-06-2025
- Dividend Yield
- PATH N/A
- CRL N/A
- EPS Growth
- PATH N/A
- CRL N/A
- EPS
- PATH N/A
- CRL N/A
- Revenue
- PATH $1,451,176,000.00
- CRL $4,022,597,000.00
- Revenue This Year
- PATH $10.73
- CRL N/A
- Revenue Next Year
- PATH $8.46
- CRL $2.49
- P/E Ratio
- PATH N/A
- CRL N/A
- Revenue Growth
- PATH 7.21
- CRL N/A
- 52 Week Low
- PATH $9.38
- CRL $91.86
- 52 Week High
- PATH $15.93
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- PATH 54.66
- CRL 62.65
- Support Level
- PATH $12.25
- CRL $146.00
- Resistance Level
- PATH $12.88
- CRL $154.43
- Average True Range (ATR)
- PATH 0.34
- CRL 4.31
- MACD
- PATH -0.01
- CRL -0.12
- Stochastic Oscillator
- PATH 58.31
- CRL 74.87
About PATH UiPath Inc.
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.